Literature DB >> 26057493

Tailoring care to haemophilia patients' needs: which specialty and when?

Massimo Morfini1, Gary Benson2, Victor Jiménez-Yuste3, Rolf Ljung4, Pier Mannuccio Mannucci5, Gianluigi Pasta6, Eduardo Remor7, Silva Zupančić Šalek8.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26057493      PMCID： PMC4624542          DOI： 10.2450/2015.0302-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  34 in total

Review 1.  Total knee replacement in haemophilia.

Authors:  N J Goddard; E C Rodriguez-Merchan; J D Wiedel
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

Review 2.  The challenge of an ageing haemophilic population.

Authors:  G Dolan
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

3.  Guidelines for the management of hemophilia.

Authors:  A Srivastava; A K Brewer; E P Mauser-Bunschoten; N S Key; S Kitchen; A Llinas; C A Ludlam; J N Mahlangu; K Mulder; M C Poon; A Street
Journal:  Haemophilia       Date:  2012-07-06       Impact factor: 4.287

4.  Management of atrial fibrillation in people with haemophilia--a consensus view by the ADVANCE Working Group.

Authors:  R E G Schutgens; R Klamroth; I Pabinger; G Dolan
Journal:  Haemophilia       Date:  2014-10-09       Impact factor: 4.287

5.  Hemophilic arthropathy. Current concepts of pathogenesis and management.

Authors:  W D Arnold; M W Hilgartner
Journal:  J Bone Joint Surg Am       Date:  1977-04       Impact factor: 5.284

Review 6.  Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.

Authors:  P W Collins; K Fischer; M Morfini; V S Blanchette; S Björkman
Journal:  Haemophilia       Date:  2010-08-22       Impact factor: 4.287

Review 7.  The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity.

Authors:  C Negrier; A Seuser; A Forsyth; S Lobet; A Llinas; M Rosas; L Heijnen
Journal:  Haemophilia       Date:  2013-03-28       Impact factor: 4.287

Review 8.  How I treat age-related morbidities in elderly persons with hemophilia.

Authors:  Pier M Mannucci; Roger E G Schutgens; Elena Santagostino; Evelien P Mauser-Bunschoten
Journal:  Blood       Date:  2009-10-16       Impact factor: 22.113

Review 9.  Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy.

Authors:  E P Mauser-Bunschoten; D E Fransen Van De Putte; R E G Schutgens
Journal:  Haemophilia       Date:  2009-02-18       Impact factor: 4.287

Review 10.  Hemophilia A in the third millennium.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Rev       Date:  2013-06-28       Impact factor: 8.250
View more
  3 in total

1.  Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials.

Authors:  Robert Klamroth; Piotr Wojciechowski; Samuel Aballéa; Françoise Diamand; Zalmai Hakimi; Jameel Nazir; Lydia Abad-Franch; Stefan Lethagen; Elena Santagostino; Michael D Tarantino
Journal:  J Blood Med       Date:  2021-02-25

2.  Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice.

Authors:  Bernd Tischer; Renato Marino; Mariasanta Napolitano
Journal:  Patient Prefer Adherence       Date:  2018-03-26       Impact factor: 2.711

Review 3.  Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review.

Authors:  Cedric Hermans; Gerry Dolan
Journal:  Ther Adv Hematol       Date:  2020-10-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.